Oncodesign
FranceOncodesign is a healthcare company, headquartered in France.
Entry
2022
Hold
4yr
Status
Active
Est. EV
–
Who owns Oncodesign?
Oncodesign is currently owned by Edmond de Rothschild Private Equity (France) through Edmond de Rothschild Equity Strategies IV (2023 vintage), since 2022. Across its history, Oncodesign has been through 4 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Edmond de Rothschild Private Equity (France)Edmond de Rothschild Equity Strategies IV · 2023 · Buyout
4 ownership periods · full history below
Key facts
HQFrance
SectorHealthcare
Key takeaways
- ·Co-held by Crédit Mutuel Equity, Eurazeo, Elyan Partners and Edmond de Rothschild Private Equity (France) since 2008.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-held by Crédit Mutuel Equity, Eurazeo, Elyan Partners and Edmond de Rothschild Private Equity (France) since 2008.
Co-invest · 4 holders · 2008 · present
2022 · present · Edmond de Rothschild Equity Strategies IV · 2023 · Buyout
MOIC
–
More from Edmond de Rothschild Equity Strategies IV
Other portfolio companies in the same fund.
Switzerland
USMore PE-backed in Healthcare
Comparable healthcare deals from other GPs.
Data refreshed weekly · Sourced from public filings